SCHEMBL14282959

SCHEMBL14282959

CCN1CCC(OC(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.69
ADRA2A P08913 3/20 0.69
CHRM1 P11229 3/20 0.69
DRD1 P21728 3/20 0.69
SLC6A2 P23975 3/20 0.69
ADRA1A P35348 3/20 0.69
DRD3 P35462 3/20 0.69
SLC6A3 Q01959 3/20 0.69
KCNH2 Q12809 3/20 0.69
OPRM1 P35372 2/20 0.69
HTR1A P08908 2/20 0.69
CYP2D6 P10635 1/20 0.69
HRH3 Q9Y5N1 1/20 0.69
MAPK1 P28482 1/20 0.67
CHRM4 P08173 2/20 0.54
CHRM5 P08912 2/20 0.54
DRD2 P14416 2/20 0.54
ADRA2B P18089 2/20 0.54
ADRA2C P18825 2/20 0.54
CHRM3 P20309 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL10436003 0.90 MAPK1 (0.59) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL14282902 0.88 DRD3 (0.69) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL14274108 0.84 CYP2D6 (0.49) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL9682033 0.83 DRD3 (0.54) CHRM2ADRA2ACHRM1DRD1SLC6A2
Hydrochloric Acid SCHEMBL1151739 0.82 MEN1 (0.58) CHRM2ADRA2ACHRM1DRD1SLC6A2
Diphenylpyraline SCHEMBL119077 0.81 DRD3 (1.00) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL6621510 0.81 CHRM2 (0.65) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL7976350 0.81 CHRM2 (0.65) CHRM2ADRA2ACHRM1DRD1SLC6A2
Hydrochloric Acid SCHEMBL11397869 0.80 MAPK1 (0.66) CHRM2ADRA2ACHRM1DRD1SLC6A2
SCHEMBL14282953 0.80 BCHE (0.59) CHRM2ADRA2ACHRM1DRD1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed